Skip to main content

Bone and Mineral Metabolism

Bone and Mineral Metabolism

Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis (EVOLVE)

EVOLVE Trial Investigators, Chertow GM, Block GA, Correa-Rotter R, Drüeke TB, Floege J, Goodman WG, Herzog CA, Kubo Y, London GM, Mahaffey KW, Mix TC, Moe SM, Trotman ML, Wheeler DC, Parfrey PS
N Engl J Med. 2012 Dec 27;367(26):2482-94

Effects of phosphate binders in moderate CKD

Block GA, Wheeler DC, Persky MS, Kestenbaum B, Ketteler M, Spiegel DM, Allison MA, Asplin J, Smits G, Hoofnagle AN, Kooienga L, Thadhani R, Mannstadt M, Wolf M, Chertow GM
J Am Soc Nephrol. 2012 Aug;23(8):1407-15

Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis

Orlando M. Gutiérrez, M.D., M.M.Sc., Michael Mannstadt, M.D., Tamara Isakova, M.D., Jose Alejandro Rauh-Hain, M.D., Hector Tamez, M.D., Anand Shah, M.D., Kelsey Smith, B.A., Hang Lee, Ph.D., Ravi Thadhani, M.D., M.P.H., Harald Jüppner, M.D., and Myles Wol
N Engl J Med. 2008 Aug 7;359(6):584-92

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK
Kidney Int. 2007 Nov;72(9):1130-7

Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis

Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P
Kidney Int. 2005 Oct;68(4):1815-24

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis

Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM
J Am Soc Nephrol. 2004 Aug;15(8):2208-18
ukidneyisup